Literature DB >> 8771068

Slow increase of homovanillic acid in cerebrospinal fluid after levodopa administration.

C Raftopoulos1, S Dethy, M A Laute, S Goldman, A B Naini, S Przedborski, J Hildebrand.   

Abstract

Concentrations of major catabolites of dopamine were followed in the ventricular cerebrospinal fluid (CSF) in five patients undergoing intracranial pressure monitoring for chronic hydrocephalus. Determinations were made every 2 h following the administration of carbidopa/levodopa 25/250 mg (one Sinemet capsule) given 8 h apart. The rise of homovanillic acid (HVA) concentrations was slow and progressive, reaching the level of statistical significance (p < or = 0.01) only 8 h after the second administration of Sinemet. The rise in 3,4-dihydroxyphenylacetic acid (DOPAC) was faster than the rise in HVA, with the peak value detected 4 h after the first administration of Sinemet. These data are interpreted as a confirmation, in humans, of a slow pool of exogenous levodopa, previously demonstrated in animal studies.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8771068     DOI: 10.1002/mds.870110111

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  4 in total

1.  The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.

Authors:  John Liggins; Robert O Pihl; Chawki Benkelfat; Marco Leyton
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

2.  Homovanillic acid and 5-hydroxyindole acetic acid as biomarkers for dementia with Lewy bodies and coincident Alzheimer's disease: An autopsy-confirmed study.

Authors:  Satoru Morimoto; Masaki Takao; Hiroyuki Hatsuta; Yasushi Nishina; Tadashi Komiya; Renpei Sengoku; Yuta Nakano; Akiko Uchino; Hiroyuki Sumikura; Yuko Saito; Kazutomi Kanemaru; Shigeo Murayama
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

3.  Impaired dopamine metabolism is linked to fatigability in mice and fatigue in Parkinson's disease patients.

Authors:  Débora da Luz Scheffer; Fernando Cini Freitas; Aderbal Silva Aguiar; Catherine Ward; Luiz Guilherme Antonacci Guglielmo; Rui Daniel Prediger; Shane J F Cronin; Roger Walz; Nick A Andrews; Alexandra Latini
Journal:  Brain Commun       Date:  2021-06-08

4.  No effect of a dopaminergic modulation fMRI task by amisulpride and L-DOPA on reward anticipation in healthy volunteers.

Authors:  Oliver Grimm; Magdalena Nägele; Lea Küpper-Tetzel; Moritz de Greck; Michael Plichta; Andreas Reif
Journal:  Psychopharmacology (Berl)       Date:  2020-11-02       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.